4.7 Article

Utility of Silver-nanoparticles for Nano Spectrofluorimetric Determination of Meropenem and Ertapenem: Bio-analytical Validation

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.saa.2021.120077

关键词

Nano analytical; Meropenem; Ertapenem; Silver nanoparticles; Europium; Bio-analytical method validation

向作者/读者索取更多资源

A bio-analytical method using silver nanoparticles to enhance the fluorescence intensity for estimating non-classical beta-lactam antibiotics meropenem and ertapenem showed good linear relationship, detection limit, and successful application in drug substances and pharmaceutical vials. The method's sensitivity and practicality facilitated direct analysis of meropenem in real plasma samples, with potential benefits for various applications exploiting enhanced fluorescence occurrence.
Bio-analytical, nano-quantitative spectrofluorimetric estimation of two non-classical beta-lactam antibiotics; meropenem (MP) and ertapenem (EP) is presented. The method is based on the enhancement of the fluorescence intensity of MP-Eu3+/EP-Eu3+ with silver nanoparticles (AgNPs). AgNPs were synthesized and characterized by UV and transmission electron microscope (TEM). The plasmon resonance produced an intense absorption maximum at 398.0 nm. TEM micrograph showed the particle morphology with an average particles size of 13.0 +/- 2.95 nm. The fluorescence intensities were measured against blank reagents at lambda em of 396.0 nm and 405.0 nm after excitation at lambda ex 305.0 nm and 303.0 nm for MP and EP, respectively. Under optimum conditions, the relative fluorescence intensity showed a good linear relationship with the concentration ranges of 4.0-14.0 and 4.0-12.0 ng/mL with excellent correlation coefficients of 0.9998 and 0.9997, and limit of detection of 0.84 and 0.86 ng/mL for MP and EP, respectively. The method was successfully applied for direct analysis of MP and EP in their drug substances and pharmaceutical vials. The significant, sensitivity and practicality of the method facilitated MP detection in real plasma samples. Bio-analytical validation was performed according to FDA. The method was rectilinear over the ranges of, 5.0-75.0 mu g/mL plasma. Interestingly, this described system has a promising benefit for various applications exploiting the dramatically enhanced-fluorescence occurrence. (C) 2021 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据